Clinical trial · Interventional
The Effect of Tennis Ball on Balance and Quality of Life in Cancer Patients With Neuropathy.
The Effect of Myofascial Release Using a Tennis Ball on Balance and Quality of Life in Cancer Patients With Peripheral Neuropathy: a Randomized Controlled Trial.
NCT06376344CI-TRIAL-00076304unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research; It was aimed to evaluate the effect of myofascial release using a tennis ball on balance and quality of life in cancer patients who developed peripheral neuropathy.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Neuropathy | — | UNRESOLVED | — |
| Therapy-Associated Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| myofascial release with tennis ball | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Study
- interventionNames
- Other: myofascial release with tennis ball
- type
- NO_INTERVENTION
- label
- Control
Primary outcomes (6)
- measure
- EORTC QLQ C-30- CIPN20 Scale
- timeFrame
- 10 minutes
- description
- The patients' quality of life will be evaluated with the EORTC QLQ-C30, which was developed by EORTC for cancer patients and is widely used all over the world. The first 28 of the scale, which consists of three subheadings and 30 questions, namely functional difficulties, symptom control and general well-being, are four-point Likert type, and the answers are given as "Not at all", "Somewhat", "2", Somewhat "3", Very "4". is evaluated. In the 29th and 30th questions of the scale, the patient is asked to evaluate his/her general well-being by using a linear analog scale and giving a value from 1 to 7 ("1" is very bad and "7" is excellent). Functional scale: physical function (questions 1-5), role function (questions 6 and 7), emotional function (questions 21-24), cognitive function (questions 20 and 25) and social function (questions 26 and 27). )consists of subgroups
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 25 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Complaints of peripheral neuropathy among patients who have completed the standard chemotherapy treatment protocol due to colorectal cancer, entered the follow-up process and come to the outpatient clinic for routine control. * Registered to Selçuk University Faculty of Medicine Hospital Medical Oncology Polyclinic * Karnofsky Performance Scale must be 80 or above * Over 25 years old, under 65 years old * Presence of grade 2 or higher peripheral neuropathy, * Being conscious and cooperative * Verbal and written approval to participate in the study after an explanation about the study is made. Exclusion Criteria: * Having any skin sensitivity on hands and feet before * Refused to participate in the study after making a statement about the study * Development of peripheral neuropathy due to reasons other than chemotherapy \[tumor compression, nutritional disorders, infections or major systemic disease (diabetes mellitus, etc.)\] * Bone or spine metastases
References
Publications (0)
Data not yet available
No reference posted for this study.